Suppr超能文献

97 例猿分枝杆菌感染的临床、影像学和微生物学特征。

Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.

机构信息

Service de Pneumologie, CHU La Réunion Site Félix Guyon, Saint Denis, France

Service de Pneumologie, CHU La Réunion Site Félix Guyon, Saint Denis, France.

出版信息

Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00395-18. Print 2018 Jul.

Abstract

is a rare species of slow-growing nontuberculous mycobacteria (NTM). From 2002 to 2017, we conducted a retrospective study that included all patients with NTM-positive respiratory samples detected in two university hospitals of the French overseas department of Reunion Island. We recorded the prevalence of in this cohort, as well as the clinical, radiological, and microbiological features of patients with at least 1 sample positive for In our cohort, 97 patients (15.1%) were positive for Twenty-one patients (21.6%) met the American Thoracic Society (ATS) criteria for infection. infection was associated with bronchiectasis, micronodular lesions, and weight loss. Antibiotic susceptibility testing was performed for 60 patients, and the isolates were found to have low susceptibility to antibiotics, except for amikacin, fluoroquinolones, and clarithromycin. Treatment failed for 4 of the 8 patients treated for infection. Here, we describe a specific cluster corresponding to a large cohort of patients with , a rare nontuberculous mycobacterium associated with low pathogenicity and poor susceptibility to antibiotics.

摘要

是一种罕见的生长缓慢的非结核分枝杆菌(NTM)。2002 年至 2017 年,我们进行了一项回顾性研究,纳入了法属留尼汪岛两个大学医院中所有分枝杆菌阳性呼吸道样本的患者。我们记录了该队列中 的流行情况,以及至少有 1 份样本分枝杆菌阳性的患者的临床、放射学和微生物学特征。在我们的队列中,97 名患者(15.1%)分枝杆菌阳性。21 名患者(21.6%)符合美国胸科学会(ATS)感染标准。分枝杆菌感染与支气管扩张、微结节病变和体重减轻有关。对 60 名患者进行了抗生素药敏试验,结果发现除阿米卡星、氟喹诺酮类和克拉霉素外,分离株对抗生素的敏感性较低。8 名接受分枝杆菌感染治疗的患者中,有 4 名治疗失败。在这里,我们描述了一个特定的集群,对应于一大群患者,这是一种罕见的非结核分枝杆菌,与低致病性和对抗生素的低敏感性有关。

相似文献

1
Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00395-18. Print 2018 Jul.
3
First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection.
Transplant Proc. 2013 Mar;45(2):803-5. doi: 10.1016/j.transproceed.2012.02.034. Epub 2012 Sep 6.
4
Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
Microb Drug Resist. 2023 Jul;29(7):302-308. doi: 10.1089/mdr.2023.0024. Epub 2023 May 23.
6
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
7
Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
J Microbiol Immunol Infect. 2010 Oct;43(5):401-6. doi: 10.1016/S1684-1182(10)60063-1.
8
[Infections due to Mycobacterium simiae].
Enferm Infecc Microbiol Clin. 2015 Oct;33(8):e37-43. doi: 10.1016/j.eimc.2014.07.008. Epub 2014 Oct 23.
9

引用本文的文献

1
Genomic diversity and clinical relevance of .
ERJ Open Res. 2024 Mar 18;10(2). doi: 10.1183/23120541.00773-2023. eCollection 2024 Mar.
2
Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products.
Curr Top Med Chem. 2024;24(15):1291-1326. doi: 10.2174/0115680266276938240108060247.
3
Molecular epidemiology of nontuberculous mycobacteria isolated from tuberculosis-suspected patients.
AMB Express. 2023 May 18;13(1):49. doi: 10.1186/s13568-023-01557-4.
4
Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018.
PLoS Negl Trop Dis. 2022 Sep 9;16(9):e0010693. doi: 10.1371/journal.pntd.0010693. eCollection 2022 Sep.
7
pulmonary infection: a case series and literature review.
Respirol Case Rep. 2021 Feb 22;9(3):e00719. doi: 10.1002/rcr2.719. eCollection 2021 Mar.
8
A case of multidrug-resistant in an elderly woman.
Respirol Case Rep. 2021 Feb 1;9(3):e00715. doi: 10.1002/rcr2.715. eCollection 2021 Mar.
9
Role of Williamsia and Segniliparus in human infections with the approach taxonomy, cultivation, and identification methods.
Ann Clin Microbiol Antimicrob. 2021 Jan 23;20(1):10. doi: 10.1186/s12941-021-00416-z.
10
Mycobacterium Simiae Infection in a Person With Cystic Fibrosis.
Cureus. 2020 Oct 20;12(10):e11062. doi: 10.7759/cureus.11062.

本文引用的文献

1
Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
Emerg Infect Dis. 2017 Mar;23(3):439-447. doi: 10.3201/eid2303.161827.
2
Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.
Pediatr Pulmonol. 2017 Mar;52(3):324-330. doi: 10.1002/ppul.23646. Epub 2017 Jan 30.
3
Computed Tomography Findings of Pulmonary Infection.
Can Respir J. 2017;2017:6913564. doi: 10.1155/2017/6913564. Epub 2017 Jan 3.
6
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease.
Int J Antimicrob Agents. 2012 Feb;39(2):173-6. doi: 10.1016/j.ijantimicag.2011.09.019. Epub 2011 Nov 17.
9
Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
Respir Med. 2008 Nov;102(11):1598-603. doi: 10.1016/j.rmed.2008.05.004. Epub 2008 Jul 10.
10
Clinical relevance of Mycobacterium simiae in pulmonary samples.
Eur Respir J. 2008 Jan;31(1):106-9. doi: 10.1183/09031936.00076107.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验